z-logo
open-access-imgOpen Access
The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC
Author(s) -
Zhi Wang,
Lingling Zhang,
Wenwen Xu,
Jie Li,
Yi Liu,
Xiaozhu Zeng,
Ming Zhong,
Zhu Yu-xi
Publication year - 2022
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s341001
Subject(s) - lung cancer , cancer research , epidermal growth factor receptor , adenocarcinoma , biology , gene , microrna , cancer , oncology , medicine , genetics
Lung cancer is a high-risk malignancy worldwide. The harboring of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) makes EGFR-tyrosine kinase inhibitor (EGFR-TKI) an attractive therapeutic option. However, patients usually suffer the primary and secondary resistance to EGFR-TKI. And the molecular alteration is still not fully clear and needs further study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here